| Participant . | Week 0 VL, copies/mL . | Week 0 HIVDR Mutations . | Week 24 VL, copies/mL . | Week 24 HIVDR Mutations . | Week 48 VL, copies/mL . | Week 48 HIVDR Mutations . | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NRTI . | NNRTI . | INSTI . | NRTI . | NNRTI . | INSTI . | NRTI . | NNRTI . | INSTI . | ||||
| A | 2860 | E44D, K65R, M184 V, K219Q | K103N, Y181C | None | <40 | NA | NA | NA | <40 | NA | NA | NA |
| B | 5860 | K65R, D67G, M184MV, K219E | V106A, G190V | None | <40 | NA | NA | NA | <40 | NA | NA | NA |
| C | 10 700 | None | E138A | None | <40 | NA | NA | NA | 320 | NA | NA | NA |
| D | 2900 | Failed RT sequencing | Failed RT sequencing | None | MV | MV | MV | MV | <40 | NA | NA | NA |
| E | 6840 | M184V | K103N,V108I | None | MV | MV | MV | MV | <40 | NA | NA | NA |
| F | <40 | NA | NA | NA | 19 100 | None | E138EA | None | <40 | NA | NA | NA |
| G | <40 | NA | NA | NA | 1440 | None | None | None | <40 | NA | NA | NA |
| H | <40 | NA | NA | NA | 12 200 | None | None | None | <40 | NA | NA | NA |
| I | 56 | NA | NA | NA | 640 | Failed RT sequencing | Failed RT sequencing | None | <40 | NA | NA | NA |
| J | <40 | NA | NA | NA | 6700 | M184MV | K103KN, V179VAIT, G190GRS | None | <40 | NA | NA | NA |
| K | <40 | NA | NA | NA | <40 | NA | NA | NA | 78 200 | None | None | None |
| L | <40 | NA | NA | NA | MV | MV | MV | MV | 506 000 | None | None | None |
| M | <40 | NA | NA | NA | MV | MV | MV | MV | 105 000 | None | K103N | None |
| N | <40 | NA | NA | NA | <40 | NA | NA | NA | 14 800 | None | None | None |
| O | <40 | NA | NA | NA | <40 | NA | NA | NA | 516 | None | K103N | None |
| P | <40 | NA | NA | NA | MV | MV | MV | MV | 258 000 | None | None | None |
| Q | <40 | NA | NA | NA | <40 | NA | NA | NA | 1 580 000 | None | None | None |
| R | <40 | NA | NA | NA | <40 | NA | NA | NA | 298 000 | None | None | None |
| S | <40 | NA | NA | NA | MV | MV | MV | MV | 11 000 | K70E, M184 V, K219R | A98G, K103N, P225H, F227L | None |
| Participant . | Week 0 VL, copies/mL . | Week 0 HIVDR Mutations . | Week 24 VL, copies/mL . | Week 24 HIVDR Mutations . | Week 48 VL, copies/mL . | Week 48 HIVDR Mutations . | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NRTI . | NNRTI . | INSTI . | NRTI . | NNRTI . | INSTI . | NRTI . | NNRTI . | INSTI . | ||||
| A | 2860 | E44D, K65R, M184 V, K219Q | K103N, Y181C | None | <40 | NA | NA | NA | <40 | NA | NA | NA |
| B | 5860 | K65R, D67G, M184MV, K219E | V106A, G190V | None | <40 | NA | NA | NA | <40 | NA | NA | NA |
| C | 10 700 | None | E138A | None | <40 | NA | NA | NA | 320 | NA | NA | NA |
| D | 2900 | Failed RT sequencing | Failed RT sequencing | None | MV | MV | MV | MV | <40 | NA | NA | NA |
| E | 6840 | M184V | K103N,V108I | None | MV | MV | MV | MV | <40 | NA | NA | NA |
| F | <40 | NA | NA | NA | 19 100 | None | E138EA | None | <40 | NA | NA | NA |
| G | <40 | NA | NA | NA | 1440 | None | None | None | <40 | NA | NA | NA |
| H | <40 | NA | NA | NA | 12 200 | None | None | None | <40 | NA | NA | NA |
| I | 56 | NA | NA | NA | 640 | Failed RT sequencing | Failed RT sequencing | None | <40 | NA | NA | NA |
| J | <40 | NA | NA | NA | 6700 | M184MV | K103KN, V179VAIT, G190GRS | None | <40 | NA | NA | NA |
| K | <40 | NA | NA | NA | <40 | NA | NA | NA | 78 200 | None | None | None |
| L | <40 | NA | NA | NA | MV | MV | MV | MV | 506 000 | None | None | None |
| M | <40 | NA | NA | NA | MV | MV | MV | MV | 105 000 | None | K103N | None |
| N | <40 | NA | NA | NA | <40 | NA | NA | NA | 14 800 | None | None | None |
| O | <40 | NA | NA | NA | <40 | NA | NA | NA | 516 | None | K103N | None |
| P | <40 | NA | NA | NA | MV | MV | MV | MV | 258 000 | None | None | None |
| Q | <40 | NA | NA | NA | <40 | NA | NA | NA | 1 580 000 | None | None | None |
| R | <40 | NA | NA | NA | <40 | NA | NA | NA | 298 000 | None | None | None |
| S | <40 | NA | NA | NA | MV | MV | MV | MV | 11 000 | K70E, M184 V, K219R | A98G, K103N, P225H, F227L | None |
Abbreviations: HIV, human immunodeficiency virus; HIVDR, HIV drug resistance; INSTI, integrase strand transfer inhibitor; NA, not applicable; NNRTI, nonnucleoside reverse transcriptase inhibitor; NRTI, nucleoside reverse transcriptase inhibitor; RT, reverse transcriptase; VL, HIV-1 RNA load; MV, missed visit.
| Participant . | Week 0 VL, copies/mL . | Week 0 HIVDR Mutations . | Week 24 VL, copies/mL . | Week 24 HIVDR Mutations . | Week 48 VL, copies/mL . | Week 48 HIVDR Mutations . | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NRTI . | NNRTI . | INSTI . | NRTI . | NNRTI . | INSTI . | NRTI . | NNRTI . | INSTI . | ||||
| A | 2860 | E44D, K65R, M184 V, K219Q | K103N, Y181C | None | <40 | NA | NA | NA | <40 | NA | NA | NA |
| B | 5860 | K65R, D67G, M184MV, K219E | V106A, G190V | None | <40 | NA | NA | NA | <40 | NA | NA | NA |
| C | 10 700 | None | E138A | None | <40 | NA | NA | NA | 320 | NA | NA | NA |
| D | 2900 | Failed RT sequencing | Failed RT sequencing | None | MV | MV | MV | MV | <40 | NA | NA | NA |
| E | 6840 | M184V | K103N,V108I | None | MV | MV | MV | MV | <40 | NA | NA | NA |
| F | <40 | NA | NA | NA | 19 100 | None | E138EA | None | <40 | NA | NA | NA |
| G | <40 | NA | NA | NA | 1440 | None | None | None | <40 | NA | NA | NA |
| H | <40 | NA | NA | NA | 12 200 | None | None | None | <40 | NA | NA | NA |
| I | 56 | NA | NA | NA | 640 | Failed RT sequencing | Failed RT sequencing | None | <40 | NA | NA | NA |
| J | <40 | NA | NA | NA | 6700 | M184MV | K103KN, V179VAIT, G190GRS | None | <40 | NA | NA | NA |
| K | <40 | NA | NA | NA | <40 | NA | NA | NA | 78 200 | None | None | None |
| L | <40 | NA | NA | NA | MV | MV | MV | MV | 506 000 | None | None | None |
| M | <40 | NA | NA | NA | MV | MV | MV | MV | 105 000 | None | K103N | None |
| N | <40 | NA | NA | NA | <40 | NA | NA | NA | 14 800 | None | None | None |
| O | <40 | NA | NA | NA | <40 | NA | NA | NA | 516 | None | K103N | None |
| P | <40 | NA | NA | NA | MV | MV | MV | MV | 258 000 | None | None | None |
| Q | <40 | NA | NA | NA | <40 | NA | NA | NA | 1 580 000 | None | None | None |
| R | <40 | NA | NA | NA | <40 | NA | NA | NA | 298 000 | None | None | None |
| S | <40 | NA | NA | NA | MV | MV | MV | MV | 11 000 | K70E, M184 V, K219R | A98G, K103N, P225H, F227L | None |
| Participant . | Week 0 VL, copies/mL . | Week 0 HIVDR Mutations . | Week 24 VL, copies/mL . | Week 24 HIVDR Mutations . | Week 48 VL, copies/mL . | Week 48 HIVDR Mutations . | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NRTI . | NNRTI . | INSTI . | NRTI . | NNRTI . | INSTI . | NRTI . | NNRTI . | INSTI . | ||||
| A | 2860 | E44D, K65R, M184 V, K219Q | K103N, Y181C | None | <40 | NA | NA | NA | <40 | NA | NA | NA |
| B | 5860 | K65R, D67G, M184MV, K219E | V106A, G190V | None | <40 | NA | NA | NA | <40 | NA | NA | NA |
| C | 10 700 | None | E138A | None | <40 | NA | NA | NA | 320 | NA | NA | NA |
| D | 2900 | Failed RT sequencing | Failed RT sequencing | None | MV | MV | MV | MV | <40 | NA | NA | NA |
| E | 6840 | M184V | K103N,V108I | None | MV | MV | MV | MV | <40 | NA | NA | NA |
| F | <40 | NA | NA | NA | 19 100 | None | E138EA | None | <40 | NA | NA | NA |
| G | <40 | NA | NA | NA | 1440 | None | None | None | <40 | NA | NA | NA |
| H | <40 | NA | NA | NA | 12 200 | None | None | None | <40 | NA | NA | NA |
| I | 56 | NA | NA | NA | 640 | Failed RT sequencing | Failed RT sequencing | None | <40 | NA | NA | NA |
| J | <40 | NA | NA | NA | 6700 | M184MV | K103KN, V179VAIT, G190GRS | None | <40 | NA | NA | NA |
| K | <40 | NA | NA | NA | <40 | NA | NA | NA | 78 200 | None | None | None |
| L | <40 | NA | NA | NA | MV | MV | MV | MV | 506 000 | None | None | None |
| M | <40 | NA | NA | NA | MV | MV | MV | MV | 105 000 | None | K103N | None |
| N | <40 | NA | NA | NA | <40 | NA | NA | NA | 14 800 | None | None | None |
| O | <40 | NA | NA | NA | <40 | NA | NA | NA | 516 | None | K103N | None |
| P | <40 | NA | NA | NA | MV | MV | MV | MV | 258 000 | None | None | None |
| Q | <40 | NA | NA | NA | <40 | NA | NA | NA | 1 580 000 | None | None | None |
| R | <40 | NA | NA | NA | <40 | NA | NA | NA | 298 000 | None | None | None |
| S | <40 | NA | NA | NA | MV | MV | MV | MV | 11 000 | K70E, M184 V, K219R | A98G, K103N, P225H, F227L | None |
Abbreviations: HIV, human immunodeficiency virus; HIVDR, HIV drug resistance; INSTI, integrase strand transfer inhibitor; NA, not applicable; NNRTI, nonnucleoside reverse transcriptase inhibitor; NRTI, nucleoside reverse transcriptase inhibitor; RT, reverse transcriptase; VL, HIV-1 RNA load; MV, missed visit.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
